Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Bioventus Inc. (BVS) vs PROCEPT BioRobotics Corporation (PRCT)

Bioventus Inc. and PROCEPT BioRobotics Corporation are both Medical Devices companies. Bioventus Inc. is the larger, with a market value of $1.1B against $1.0B — 1.1× the size. PROCEPT BioRobotics Corporation has negative trailing earnings, so its P/E is not meaningful; Bioventus Inc. trades at 17.0×. PROCEPT BioRobotics Corporation grew revenue faster over the last twelve months: 22.7% against 3.14%. Bioventus Inc. has the higher net margin (9.36% vs −32.5%) and the higher return on invested capital (7.34% vs −43.6%). Across the 19 metrics below, Bioventus Inc. leads on 14 and PROCEPT BioRobotics Corporation on 5.

Valuation

Metric BVS PRCT Medical Devices median
P/E 17.05 n/m 22.18
P/S 1.61 2.91 2.70
P/B 3.38 2.89 2.46
Price to free cash flow 9.94 n/m 22.53
EV/EBITDA 11.17 n/m 11.78
EV/Sales 1.99 2.39 2.38
Earnings yield 5.87% (11.28%) (8.22%)
Free cash flow yield 10.06% (8.65%) (7.80%)

Profitability

Metric BVS PRCT Medical Devices median
Gross margin 68.65% 64.22% 56.01%
Operating margin 10.02% (33.86%) (15.03%)
Net margin 9.36% (32.54%) (20.40%)
Free cash flow margin 16.20% (25.17%) (7.24%)
Return on equity 22.75% (30.24%) (15.32%)
Return on assets 7.89% (22.12%) (19.72%)
Return on invested capital 7.34% (43.57%) (10.33%)

Growth

Metric BVS PRCT Medical Devices median
Revenue growth (TTM) 3.14% 22.69% 8.80%
EPS growth (last fiscal year) 163.46% 1.71% —
Revenue growth, 5-year CAGR 12.08% 109.04% 15.23%
Net income growth, 5-year CAGR 6.73% 0.00% 0.00%

Health

Metric BVS PRCT Medical Devices median
Debt to equity 0.90 0.15 0.07
Current ratio 1.69 6.55 2.50
Net debt to EBITDA 2.40 2.41 0.49

Dividend

Metric BVS PRCT Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric BVS PRCT Medical Devices median
Market cap 1.13b 1.01b 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack